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The neuroregenerative effects of topical
decorin on the injured mouse cornea
Mengliang Wu1, Laura E. Downie1, Liam M. Grover2, Richard J. A. Moakes2, Saaeha Rauz3,4, Ann Logan4,
Haihan Jiao1, Lisa J. Hill5 and Holly R. Chinnery1*
Abstract
Background: The cornea is innervated with a rich supply of sensory nerves that play important roles in ocular
surface health. Any injury or pathology of the corneal nerves increases the risk of dry eye disease and infection. This
study aims to evaluate the therapeutic potential of topical decorin to improve corneal nerve regeneration in a
mouse model of sterile epithelial abrasion injury.
Methods: Bilateral central corneal epithelial abrasions (2-mm, Alger Brush) were performed on young C57BL/6 J
mice to remove the corneal sensory nerves. Decorin, or vehicle, was applied topically, three times per day for 1
week or every 2 h for 6 h. Spectral-domain optical coherence tomography was performed to measure the abrasion
area and corneal thickness. Wholemount immunofluorescence staining was used to assess sensory nerve
regeneration (β-tubulin III) and immune cell density (CD45, Iba1, CD11c). To investigate the specific role of dendritic
cells (DCs), Cx3cr1gfp/gfp mice, which spontaneously lack resident corneal epithelial DCs, were also investigated. The
effect of prophylactic topical administration of recombinant human decorin (applied prior to the abrasion) was also
investigated. Nerve tracing (NeuronJ software) was performed to compare recovery of basal nerve axons and
superficial nerve terminals in the central and peripheral cornea.
Results: At 6 h after injury, topical decorin application was associated with greater intraepithelial DC recruitment
but no change in re-epithelialisation or corneal thickness, compared to the vehicle control. One week after injury,
sub-basal nerve plexus and superficial nerve terminal density were significantly higher in the central cornea in the
decorin-treated eyes. The density of corneal stromal macrophages in the decorin-treated eyes and their
contralateral eyes was significantly lower compared to saline-treated corneas. No significant improvement in
corneal nerve regeneration was observed in Cx3cr1gfp/gfp mice treated with decorin.
Conclusions: Decorin promotes corneal epithelial nerve regeneration after injury. The neuroregenerative effect of
topical decorin was associated with a higher corneal DC density during the acute phase, and fewer macrophages at
the study endpoint. The corneal neuroregenerative effects of decorin were absent in mice lacking intraepithelial
DCs. Together, these findings support a role for decorin in DC-mediated neuroregeneration following corneal
abrasion injury.
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Background
The cornea contains the highest density of sensory
nerves and nociceptors compared to any other tissue in
the body. The sensory nerve supply to the cornea origi-
nates from the ophthalmic division of the trigeminal
nerve. Large nerve trunks enter the cornea at the periph-
eral limbus and form a network of stromal nerve trunks
that turn anteriorly towards the epithelium at the ocular
surface [1]. Unmyelinated nerve branches penetrate the
epithelial basement membrane, divide further and run
parallel along the basal epithelium towards the central
cornea, forming the sub-basal nerve plexus (SBNP) [2].
Several nerve branches of the SBNP turn upward, pene-
trating vertically through the epithelium, and terminate
just beneath the epithelial surface as superficial nerve
terminals (SNT) [2]. This rich supply of unmyelinated
peripheral nerves serves critical functions in maintaining
homeostasis of the corneal epithelium and the ocular
surface, orchestrating rapid responses to external stimuli
with blinking, tear production and the release of numer-
ous tropic substances, such as substance P, neurotrans-
mitters and neuropeptides [3, 4]. A range of ocular
surface conditions, including viral infections, chemical
and physical burns, topical drug preservatives and cor-
neal surgeries, can cause corneal neuropathy, which in
turn can lead to chronic pain and dry eye disease [5, 6].
Systemic diseases such as diabetes mellitus can also
negatively affect corneal nerve density and function [7,
8], thus compromising the integrity of the ocular
surface.
Following experimental induction of a corneal epithe-
lial abrasion in mice, recovery of the SBNP is typically
incomplete by 4 weeks post-injury [9–11]. However, the
apically located SNTs regenerate faster than the SBNP,
providing evidence that these two inter-connected plexi
have differential rates of recovery after injury [9]. Fol-
lowing stromal transection injury in mice, the density of
the SBNP recovered to baseline levels after 6 weeks [12].
In humans, laser in situ keratomileusis (LASIK), the
most common refractive surgery procedure, results in an
80% decrease in SBNP density at 5 days after surgery
[13]. Restoration of the SBNP density to pre-operative
levels takes at least 3 years [14, 15]. Furthermore, it is
well established that during the first few months post-
LASIK, about 30–40% of patients develop symptoms of
dry eye disease [16] which has been linked to corneal
epithelial sensory nerve damage [6, 17]. Current therap-
ies, such as ocular lubricants, help alleviate ocular sur-
face symptoms but do not treat the aetiology of the
condition related to corneal denervation. Some factors,
including nerve growth factor (NGF) and pigment
epithelium-derived factor (PEDF), have been shown to
be effective at accelerating corneal sensitivity after LA-
SIK [18] and in promoting corneal nerve regeneration in
preclinical models of nerve injury post-viral infection
[19] respectively.
Although the cornea is avascular, several studies have
characterised the resident immune cells that exist in the
corneal stroma (mostly macrophages, with a small popu-
lation of CD11c+ dendritic cells (DCs) [20, 21]) and epi-
thelium (almost exclusively CD11c+ DCs [22–25]). In
addition to co-ordinating innate inflammatory responses
after injury [26, 27], these cells also contribute to main-
tenance of nerves and lymphatic vessels [23, 28]. The
macrophages, distributed predominantly in the anterior
stroma, appear to make physical contacts with corneal
nerve trunks in the peripheral cornea [29]. The intrae-
pithelial CD11c+ DCs decrease in density from the per-
ipheral limbus to the central cornea [20, 21, 30]. Using
an inducible model of DC depletion (CD11c-DTR mice),
Gao et al. showed that resident corneal DCs contribute
to corneal nerve density during homeostasis and after
sterile injury [23] via production of ciliary neurotrophic
nerve factor (CNTF). In the healthy human cornea, the
density of corneal nerves was positively correlated with
resident corneal DC density, suggesting an interaction
between corneal nerves and immune cells even in steady
state conditions [31, 32].
Decorin is a small, leucine-rich proteoglycan that
exists in most connective tissues, including in the tra-
becular meshwork, sclera and cornea of the eye [33].
Although decorin is considered a structural compo-
nent of the extracellular matrix, it mediates a diverse
range of cellular processes including collagen fibrillo-
genesis, wound healing, fibrosis, neovascularisation
and inflammation [34]. In the cornea, impaired ex-
pression of decorin, caused by a frameshift mutation,
is responsible for opacification in congenital stromal
corneal dystrophy [35]. It has also been reported that
decorin plays anti-fibrotic roles in animal models of
proliferative vitreoretinopathy and Pseudomonas kera-
titis [36, 37]. In a rabbit model of corneal neovascu-
larisation (CNV), decorin gene therapy delivered with
adeno-associated virus serotype 5 decreased CNV,
through a mechanism involving downregulation of
vascular endothelial growth factor expression [38].
Notably, in the central nervous system, decorin has
been reported to promote nerve axon growth follow-
ing spinal cord injury in vivo, and in the cultured
dorsal root ganglia [39–41]. In addition, decorin has
been reported to regulate inflammation in in vitro
studies, including rescuing macrophages from apop-
tosis and enhancing their activation by blocking en-
dogenously produced transforming growth factor beta
(TGF-β) [42, 43]. However, the effect of decorin on
corneal nerve regeneration has not been previously
investigated. Therefore, the aim of this study was to
assess the effects of topical human recombinant
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decorin on corneal nerve regeneration in a well-
established murine model of epithelial abrasion injury.
In addition, changes to corneal immune cells were in-
vestigated to explore the potential mechanism(s) in-
volved in the neuroregenerative response.
Materials and methods
Animals
Wild-type female C57BL6 mice (6–8 weeks old) were
purchased from the Animal Resources Centre, Murdoch,
Western Australia, and housed in a specific pathogen-
free environment at the Florey Institute of Neuroscience
and Mental Health. Cx3cr1-deficient (Cx3cr1 gfp/gfp)
mice that spontaneously lack resident corneal epithelial
DCs [44] and CD11c-eYFP reporter mice that harbour
transcriptional control of the mouse integrin alpha X
(CD11c) promoter, thus labelling resident corneal DCs,
were included in the study. All animals were treated in
accordance with the ARVO Statement for the Use of
Animals in Ophthalmic and Vision Research, and all
procedures were approved by the Animal Ethics Com-
mittee at the Florey Institute of Neuroscience and Men-
tal Health (18-094-UM).
Spectral domain optical coherence tomography
In vivo spectral domain optical coherence tomography
(SD-OCT) imaging was performed to measure the cor-
neal wound sizes at baseline (time 0 hours [h]) and to
measure corneal epithelial and stromal thickness at the
experimental endpoint. Corneal epithelial thickness was
quantified as a safety measure, to exclude the possibility
of any unexpected effects of decorin on corneal epithe-
lial wound healing and to verify that decorin did not in-
fluence epithelial cell proliferation or oedema.
Anesthetised mice were placed on the animal imaging
mount and rodent alignment stage (AIM-RAS) attached
to the SD-OCT imaging device (Bioptigen Envisu R2200
VHR; Bioptigen, Inc., Durham, NC, USA). Volumetric 3
× 3-mm rectangular scans of the central cornea (1000
A-scans/200 B-scans) were captured using an 18-mm
telecentric lens at baseline and immediately after the
abrasion (0 h), 6 h and 1-week post corneal injury. Cen-
tral corneal thickness (CCT) was measured as previously
described [45] using ImageJ software (http://imagej.nih.
gov/ij/; provided in the public domain by the National
Institutes of Health, Bethesda, MD, USA). En face im-
ages were used to measure the size of the epithelial abra-
sion area using a freehand trace tool in ImageJ.
Corneal abrasion injury
Mice were anesthetised with an intraperitoneal injection
of a ketamine (80 mg/kg) and xylazine (10 mg/kg) di-
luted with saline. A corneal abrasion injury was per-
formed on both eyes of each animal as described
previously [9]. In brief, an approximately 2-mm diameter
circular area of the central corneal epithelium was de-
marcated using a sterile 2-mm trephine, then debrided
using an ophthalmic burr (0.5 mm, Algerbrush II; Alger
Equipment Co., Lago Vista, TX, USA). Immediately fol-
lowing debridement, a 2-μl drop of sterile saline was ap-
plied to each eye to prevent corneal drying.
Preparation of decorin, decorin fluid gel and fluid gel eye
drops
Decorin fluid gels and fluid gels (without decorin) were
produced using low acyl gellan gum (Kelco gel CG LA,
Azelis, UK) as previously described [46]. The fluid gels
were used to provide localised drug delivery and im-
proved retention on the ocular surface [37]. The fluid
gels are optically transparent and are naturally removed
through shear forces generated with blinking over a dur-
ation of 4–6 h. The decorin fluid gel formulation was
prepared by adding human recombinant decorin (4.76
mg/ml; GalacorinTM, Catalent Pharma Solutions, NJ,
USA) in phosphate-buffered saline (PBS) and aqueous
sodium chloride (0.2 M), with the final concentrations of
0.9% (w/v) gellan, 0.24 mg/ml decorin and 10mM NaCl.
The fluid gel (without decorin) was adjusted to a final
composition of 0.9% (w/v) gellan and 10mM NaCl.
Topical treatment
Mice received eye drops (5 μl of either decorin (4.76 mg/
ml in PBS; GalacorinTM, Catalent, USA), saline, decorin
fluid gel or fluid gel only) either three times per day for
1 week (1-week timepoint; see Experiment 1, Fig. 1) or
three times administered at two hourly intervals over a
6-h period (see Experiment 2, Fig. 1). Mice were held for
1 min after each eye drop to allow the eye drops to dis-
tribute across the ocular surface. A small group of
CD11c-eYFP mice (n = 5) was included in Experiment 2
to verify that intraepithelial CD45+ DCs expressed
CD11c+ (see Supplemental file Fig. S1).
Role of DCs in corneal nerve regeneration
Cx3cr1 gfp/gfp mice lack resident corneal epithelial
DCs [44]. To investigate the potential role of resident
and early infiltrating DCs in corneal nerve regener-
ation, a group of Cx3cr1gfp/gfp mice (n = 8) and wild-
type C57BL/6 J mice (n = 8) were examined 1 week
after a ~ 2-mm corneal epithelial injury and daily ap-
plication of either decorin or saline eye drops (see
Experiment 3, Fig. 1).
To determine whether topical application of decorin
on an intact cornea could induce corneal DC infiltration,
wild-type C57BL6 mice (n = 3) received topical decorin
every 2 h for 6 h before euthanasia. To determine
whether preconditioning with decorin could impart a
protective effect prior to corneal epithelial injury, pre-
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treatment with decorin eye drops or vehicle was applied
3 times at 2 hourly intervals at -6 h, -4 h, -2 h pre-injury
(0 h). Mice were euthanised after 1 week, and the extent
of corneal nerve regeneration was quantified (see Experi-
ment 4, Fig. 1).
Wholemount immunofluorescence
Mice were euthanised, and dissected corneas were
fixed in 100% methanol for 1 h at 4 °C and then
washed in PBS. Corneal flat mounts were incubated
in 20 mM ethylenediaminetetraacetic acid for 60 min
at 37 °C and blocked with 3% bovine serum and
0.3% Triton X-100 in PBS for 60 min at room
temperature. For immunostaining, tissues were incu-
bated overnight at 4 °C with primary antibody rabbit
anti-β tubulin III (1:500; #T2200, Sigma, St Louis,
MO, USA) and rat anti-CD45 (1:500; #550539, BD
Biosciences, Franklin Lakes, NJ, USA) or rabbit anti-
Iba1 (1:500; #019-19741, Wako, Osaka, Japan) and
rat anti-Ki67 (1:500; #14-5698-80, eBiosciences,
Carlsbad, CA, USA). Afterwards, tissue flat mounts
were washed with PBS before incubation with the
secondary antibodies, goat anti-rabbit Alexa Fluor
647 (1:500; #A21244, ThermoFisher Scientific, Carls-
bad, CA, USA) and goat anti-rat Alexa Cy3 (1:500;
#A10522, ThermoFisher Scientific, Carlsbad, CA,
USA) and Hoechst (1:1000; Sigma, St Louis, MO,
USA) for 120 min at room temperature. Immuno-
stained samples were then washed and mounted
onto glass slides with aqueous mounting medium
and coverslipped for imaging.
Corneal nerve and immune cell image acquisition and
analysis
Corneal whole mounts were imaged using a confocal
microscope with a × 40 objective lens (Confocal Laser
Scanning Microscopy SP8; Leica Microsystems, Buf-
falo Grove, IL, USA). Three non-overlapping z-series
(z-step size 1 μm, image size 290 × 290 μm) were cap-
tured from the central (within central 1.5 mm of the
cornea) and peripheral cornea (between 2 mm and
2.5 mm from the centre of the cornea) respectively.
Separate z-stacks of the SNTs and SBNP were created
by generating z-projections of the superficial and
Fig. 1 Schematic diagram of the study timepoints and specific treatments for the four complementary experimental components. Experiment 1:
After corneal abrasion, wild-type mice received eye drops 3 times per day for 1 week; Experiment 2: After corneal abrasion, wild-type mice
received eye drops every 2 h (0 h, 2 h, 4 h) and were then euthanised at 6 h; Experiment 3: After corneal abrasion, Cx3cr1gfp/gfp and wild-type
mice received eye drops 3 times per day for 1 week; Experiment 4: wild-type mice received eye drops every 2 h (-6 h, -4 h, -2 h) before abrasion
(0 h), and were then housed for 1 week without further treatment
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basal epithelial layers [9, 47]. To compare the innate
inflammatory response between groups, z-stack im-
ages of the anterior corneal stroma (5 μm directly
below the basal epithelium) were created for analysing
neutrophils (CD45+ Iba1− with a distinct polymorpho-
nuclear appearance) and macrophages (CD45+ Iba1+).
For analysis of DC density, distribution and dendritic
field area, one image was collected from the central
cornea and three images from the peripheral cornea
using an Olympus BX51 microscope with a × 10 ob-
jective lens (900 μm × 600 μm area).
Image analysis
All images were analysed by a masked observer. The
sum length of SNTs and SBNP was quantified using the
NeuronJ plugin in ImageJ software for manual nerve tra-
cing as previously described [9, 47, 48]. The density of
macrophages, neutrophils and DCs was counted manu-
ally, and density of Ki67+ve epithelial cells was analysed
using automated threshold counting in ImageJ. Macro-
phages were identified by CD45+ Iba1+ staining and lo-
cation within the stroma. DCs were identified by being
CD45+ and displaying a distinct dendriform morphology
and location within the epithelium.
Statistical analyses
For the mice who received different treatments in each
eye, the data analysis was performed by fitting a linear
mixed-effects model using restricted maximum likeli-
hood (REML) and Kenward-Roger tests for fixed effects.
The model included fixed effects of decorin, fluid gel
and contralateral effects along with the two-way interac-
tions of decorin and gel, and gel and contralateral effect.
The mouse model was included as a random effect to
account for correlation between the eyes of a particular
animal. After fitting the model, post hoc tests were per-
formed to examine the three main effects including dec-
orin, fluid gel and any potential ‘contralateral eye effect’
from the decorin intervention. For the experiments only
involving application of decorin and saline, a Wilcoxon
Signed Ranks test or Wilcoxon Rank-Sum test was per-
formed. All statistical analyses were performed in Stata
software (version 14.2; StataCorp LLC, College Station,
TX, USA). A p < 0.05 was considered statistically signifi-
cant. All summary data are shown as mean ± SD.
Results
Corneal neuroregenerative and inflammatory effects of
decorin at 1 week
For all experiments, the abrasion injury was photo-
graphed for every animal to ensure similar wound
sizes were generated in all mice. In Experiment 1, the
baseline corneal epithelial injury was 2.83 ± 0.50 mm2
(mean ± SD), with no inter-group difference in injury
size before the topical treatments (see Supplemental
file 2). Table 1 summarises results from the mixed-
effects statistical models on corneal nerve regener-
ation and immune cell density, including the effects
of decorin, fluid gel, the potential contralateral eye ef-
fect and their interactions. The eyes treated with dec-
orin showed greater corneal nerve regeneration in the
central cornea compared to those without (SNT 1806
± 402 vs 1355 ± 443 μm, p = 0.027; SBNP 3208 ±
1085 vs 1963 ± 1196 μm, p = 0.006). This effect was
not observed in the peripheral cornea, which was the
area adjacent to the 2-mm wound margin (Fig. 2).
There was no difference between fluid gel + decorin
and decorin alone observed for all measurements, in-
dicating that the decorin fluid gel did not provide any
additional improvement to the effect of decorin alone.
Macrophage density in the anterior stroma and DC
density in the epithelium were quantified in the central
and peripheral cornea (Fig. 3). At 1 week, the density of
macrophages was significantly lower in decorin-treated
eyes at both corneal eccentricities (Fig. 3a and b; p <
0.001 and p = 0.001, respectively). Interestingly, the
saline-treated corneas contralateral to decorin-treated
corneas had a lower density of macrophages in both the
central and peripheral cornea (p = 0.007 and 0.002 re-
spectively) compared to corneas that received saline or
fluid gel only, suggesting a contralateral eye effect of
decorin on macrophage density. At the 1-week time-
point, there was no difference in DC density in corneas
treated with topical decorin, decorin fluid gel or fluid gel
(Fig. 3c and d).
To verify that topical application of decorin did not in-
duce any unexpected corneal inflammation, epithelial
thickness (see Supplemental file 3A-C, in vivo SD-OCT)
and cell proliferation (Supplemental file 3D-F, ex vivo
Ki67 staining) were assessed. There were no differences
in epithelial cell proliferation or corneal thickness after
applying decorin and/or the fluid gel for 1 week.
Effect of topical decorin on corneal immune cells and re-
epithelialisation at 6 h
In order to explore whether the increased nerve re-
generation in decorin-treated corneas was due to fas-
ter re-epithelialisation after injury and if there were
any differences in the number or distribution of in-
flammatory cells during the acute phase of wound
healing, a similar experiment was conducted, but tis-
sues examined after 6 h (Experiment 2). The results
are summarised in Table 2. Topical application of
decorin and/or the fluid gel did not alter the extent
of re-epithelialisation relative to the saline control
(Supplemental file 4A-C). Eyes treated with the fluid
gel had a higher stromal thickness at 6 h compared to
those without (p = 0.002) (Supplemental file 4D).
Wu et al. Journal of Neuroinflammation          (2020) 17:142 Page 5 of 14
Fig. 2 Experiment 1: Corneal nerve regeneration after 1 week of topical decorin treatment, dosed 3 times/day. a–d Representative confocal
images of the SNTs and SBNP in the central cornea after saline (a, c) and decorin (b, d) topical treatment. e–f Quantification of the sum length of
SNTs in the central and peripheral cornea. g–h Sum length of the SBNP in the central and peripheral cornea. Summary data are shown as mean
± SD. Scale bar in d (50 μm) applies to all images. Red symbols in e–h represent the contralateral eye of the decorin-treated eye. Asterisk
indicates a statistically significant difference between eyes with and without decorin treatment. P values for each of the inter-group comparisons
are provided in Table 1. Legend: DCN, decorin; Gel, fluid gel
Table 1 Experiment 1: Comparison of corneal nerve parameters and immune cell densities in eyes with different topical treatments
after 1 week
Main effects Interactions
Decorin Fluid gel Contralateral eye effect Decorin # Gel Gel # Contralateral
Contrast (95% CI) p value Contrast (95% CI) p value Contrast (95% CI) p value p value p value
Central cornea
SNT (μm) 402.1 (49.0, 755.2) 0.027 277.0 (− 125.3, 679.3) 0.166 − 103.2 (− 456.4, 249.9) 0.552 0.840 0.249
SBNP (μm) 1350.0 (427.3, 2272.7) 0.006 152.9 (− 871.6, 1177.3) 0.758 159.6 (− 763.1, 1082.3) 0.725 0.155 0.687
DCs (cells/mm2) 0.3 (− 1.9, 2.6) 0.781 − 1.8 (− 4.2, 0.6) 0.138 0.0 (− 2.3, 2.2) 0.968 0.301 0.469
Macrophages (cells/mm2) − 72.6 (− 109.2, − 36.1) < 0.001 16.1 (− 25.7, 58.0) 0.430 − 52.0 (− 88.5, − 15.4) 0.007 0.925 0.787
Ki67+ (cells/mm2) 265.1 (− 126.9, 657.0) 0.177 − 22.6 (− 446.2, 401.0) 0.912 − 41.2 (− 433.2, 350.7) 0.831 0.103 0.557
Peripheral cornea
SNT (μm) 109.9 (− 181.4, 401.2) 0.446 221.5 (− 102.0, 545.0) 0.168 − 26.5 (− 317.8, 264.8) 0.853 0.253 0.801
SBNP (μm) 475.4 (− 706.4, 1657.2) 0.414 413.9 (− 958.6, 1786.5) 0.535 149.5 (− 1032.3, 1331.3) 0.796 0.530 0.851
DCs (cells/mm2) 0.0 (− 3.9, 4.0) 0.984 0.9 (− 3.5, 5.3) 0.670 − 1.3 (− 5.2, 2.7) 0.523 0.108 0.713
Macrophages (cells/mm2) − 45.7 (− 70.9, − 20.4) 0.001 14.7 (− 13.5, 43.0) 0.288 − 42.9 (− 68.1, − 17.6) 0.002 0.855 0.695
Ki67+ (cells/mm2) 63.6 (− 253.2, 380.5) 0.684 − 150.3 (− 495.8, 195.2) 0.373 83.2 (− 233.7, 400.0) 0.595 0.224 0.095
Corneal thickness at apex
Epithelium (μm) 0.7 (− 1.0, 2.4) 0.400 1.3 (− 0.6, 3.3) 0.170 1.1 (− 0.6, 2.9) 0.193 0.910 0.727
Stroma (μm) 0.2 (− 2.6, 3.1) 0.868 − 1.8 (− 5.1, 1.5) 0.259 1.7 (− 1.2, 4.6) 0.231 0.189 0.054
Statistics are derived from a mixed-effects model. Data are also shown in Figs. 2, 3 and Supplemental file Fig. S3. P value indicates the significance of the contrast between the
eyes with or without the intervened effect (decorin, fluid gel and etc.)
CI confidence interval, DCs dendritic cells, SBNP Sub-basal nerve plexus, SNT superficial nerve terminals
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DC density was significantly higher (p < 0.001) in
the peripheral cornea of the eyes treated with decorin
(Fig. 4a–c) compared to those without decorin treat-
ment, while no difference was observed in the field
area of DCs (Fig. 4d). Compared to the finding after
1 week of decorin treatment where macrophage num-
bers were reduced, there was no effect on macro-
phage density with decorin at 6-h post-injury (Fig.
4e–k). The density of infiltrated neutrophils at 6-h
post-injury showed no difference between the eyes
with different treatments (Fig. 4l).
Corneal neuroregenerative effect of topical decorin in
Cx3cr1gfp/gfp mice
Based on previous reports of the role of resident
corneal epithelial DCs in epithelial nerve recovery
after injury [23], Cx3cr1gfp/gfp mice were used to in-
vestigate whether the decorin-mediated nerve regen-
eration would occur in the absence of resident
epithelial DCs (Experiment 3). As expected,
Cx3cr1gfp/gfp mice showed fewer DCs in the central
and peripheral cornea compared to WT mice after 1
week (Fig. 5a and b). Consistent with the previous
experiments, the density of macrophages was similar
between paired eyes receiving decorin and saline,
due to the contralateral effect of decorin on macro-
phage density (Fig. 5c). Notably, the decorin-treated
eye in WT C57BL/6 J mice showed improved SBNP
regeneration (p = 0.039), but this effect was not ap-
parent in Cx3cr1gfp/gfp mice (Fig. 5d). There was no
significant inter-group difference for SNT regener-
ation (Fig. 5e).
Corneal neuroregenerative and immunomodulatory
effects of topical decorin treatment administered 6 h
prior to injury
To determine if topical application of decorin on the
intact cornea could act as a chemoattractant, DCs
Fig. 3 Experiment 1: Changes to corneal immune cells after 1 week of topical treatment, dosed 3 times/day. a–c Representative confocal images
of the anterior stromal CD45+ Iba1+ macrophages in the central cornea of naïve (a1–a4), saline-treated (b1–b4) or decorin-treated eye (c1–c4).
Scale bar in c4 (50 μm) applies to all images. d, e Density of anterior stromal macrophages in the central and peripheral cornea. f, g Density of
epithelial DCs in the central and peripheral cornea. Summary data are shown as mean ± SD. Each data point represents a single cornea. Red
symbols represent the contralateral eye of the decorin-treated eye. Asterisk indicates a statistically significant difference between eyes with and
without decorin treatment. P values for each of the inter-group comparisons are provided in Table 1. Legend: DCN, decorin; Gel, fluid gel
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were quantified in the corneal epithelium, 6 h after
the instillation of eye drops (3 doses, every 2 h) on
healthy, uninjured eyes. A higher density of DCs in
the peripheral, but not the central, cornea was ob-
served (Supplemental file 5A&B). To investigate the
possibility that pre-conditioning decorin treatment
could induce a higher density of DCs and promote
corneal nerve regeneration, decorin-treated mice re-
ceived topical decorin prior to epithelial abrasion
and were housed for 1-week after injury without any
further topical treatments. No significant inter-group
difference in the extent of corneal nerve regeneration
(in the SNTs or SBNP) or immune cell density (DCs
and macrophages) was observed at 1 week
(Supplemental file 5C-F), suggesting decorin pre-
injury short-pulse pre-conditioning is not effective at
promoting corneal nerve recovery after epithelial
injury.
Discussion
Corneal sensory nerves are vital for maintaining epithe-
lial integrity [49]. It follows that corneal nerve dysfunc-
tion is the pathophysiologic basis of a variety of ocular
surface diseases. During the corneal nerve regenerative
process, the eye is vulnerable to dry eye disease and epi-
thelial erosions, which can cause ocular pain and dis-
comfort. Clinical studies show that it can take several
years for corneal nerves to completely regenerate after
Fig. 4 Experiment 2: Changes to immune cells after 6-hours of topical treatment (i.e., 3 × doses, 2 hours apart). a–c Representative
immunofluorescence images from the peripheral corneas of naïve (a), decorin-treated injured (b) and saline-treated injured (c) eyes. Arrows
indicate intraepithelial CD45+ DCs. Scale bar in c (100 μm) applies to a–c. d Density of DCs in the peripheral corneal epithelium after 6 h of
treatment. e–h Representative confocal images of CD45+ Iba1+ cells in the peripheral corneal stroma. Scale bar in h (50 μm) applies to e–h. i A
higher magnification and merged image of the boxed area in e and f. Arrowheads indicate CD45+ Iba1+ stromal macrophages; asterisks indicate
CD45+ Iba1− neutrophils. j A higher magnification image of the boxed area in g. Asterisks indicate distinct polymorphonuclear appearance of
neutrophil nuclei. k, l Density of macrophages and neutrophils in the peripheral corneal stroma after 6 h of treatment. Summary data are shown
as mean ± SD. Each data point represents one cornea. Red symbols in f–i represent the contralateral eye of the decorin-treated eye. Asterisk
indicates a statistically significant difference between eyes with and without decorin treatment. P values for each of the inter-group comparisons
are provided in Table 2. Legend: DCN, decorin; Gel, fluid gel
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surgical-induced ablation [14, 15, 50], potentially leading
to secondary ocular surface conditions, such as dry eye
disease and neurotrophic keratopathy [17, 49, 51]. Des-
pite the clinical importance of treatments to promote
corneal nerve regeneration, there are relatively few
therapeutic approaches. Some clinical studies have re-
ported corneal neuroregenerative effects with topical or
oral omega-3 fatty acid supplementation in individuals
with damaged corneal nerves [52, 53]. However, there
are currently few therapies available to improve nerve
regeneration after injury. In the present study, we exam-
ined whether topical decorin influenced corneal nerve
regeneration after sterile injury. Using a mouse model of
central corneal epithelial abrasion, which removes all
sensory nerves at the site of injury, we showed that cor-
neal nerve fibre length was higher after 1 week of topical
decorin therapy relative to inactive topical treatment
(i.e., saline or fluid gel). Furthermore, topical decorin
treatment was associated with a higher density of intrae-
pithelial DCs during the acute phase (6 h post injury),
and a lower density of stromal macrophages at 1 week.
Esquenazi et al. reported that recombinant mature
NGF treatment improved corneal nerve regeneration at
8 weeks after photorefractive keratectomy (PRK) in a
rabbit model [54]. Interestingly, their study also showed
increased epithelial cell proliferation after NGF
treatment, providing evidence of an interaction between
corneal nerves and epithelial cells. The epithelium can
provide anatomical structural support for corneal sen-
sory nerves and release neurotrophic mediators that in-
duce neurite survival [55]. In the present study, we did
not find any difference in corneal re-epithelialisation ei-
ther by in vivo SD-OCT imaging or epithelial cell prolif-
eration (by Ki-67 staining) at 1 week after topical
decorin treatment. These results suggest that decorin
may exert its effect on corneal nerve regeneration by
other mechanisms.
Decorin is a known inhibitor of TGF-β, binding to and
neutralising its biological activities and regulating TGF-β
signalling pathways by interacting with low density lipo-
protein receptor-related protein-1 (LRP-1) [56]. More-
over, decorin can interact with many immune-related
proteins including Toll-like receptors that are involved
in the regulation of inflammation [57] and Class A scav-
enger receptors that are specifically expressed on macro-
phages [58]. Interestingly, mounting evidence highlights
that there is a strong interaction between corneal in-
flammation and nerve regeneration [59, 60]. In a mouse
model of corneal lamellar transection surgery, Namavari
et al. [61] reported that Sema7A, an axon guidance fac-
tor, can promote corneal nerve regeneration and in-
crease inflammatory cell influx (CD11b+ cells and CD3+
Fig. 5 Experiment 3: Corneal immune cell density and nerve regeneration in Cx3cr1gfp/gfp mice after 1-week of topical treatment with saline or
decorin (DCN). a–b Density of epithelial DCs in the central and peripheral cornea. c–d Density of anterior stromal macrophages in the central and
peripheral cornea. e–f Quantification of the sum length of the SNTs and SBNP in the central cornea respectively. Summary data are shown as
mean ± SD. Asterisk indicates significant difference between saline-treated and decorin-treated eyes. Each data point represents 1 cornea.
Legend: DC, dendritic cell; DCN, decorin; WT, wild-type; n = 8 WT, n = 7 Cx3cr1gfp/gfp mice
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lymphocytes) into the cornea, suggesting Sema7A may
act as a neurotrophic factor by regulating inflammatory
processes. However, this study only assessed the total
length of nerves in the epithelium and stroma. It is un-
clear if the SBNP and SNTs recovered at similar rates or
if any topographical differences in nerve recovery in re-
sponse to Sema7A existed. In contrast, our study finds
that corneal stromal macrophages, but not epithelial
DCs, have a lower density after 1 week of topical decorin
treatment; these findings suggest that decorin may exert
immunomodulatory effects in the cornea post-injury.
Similar to our findings, He et al. observed a faster reso-
lution of CD4+ and CD11b + cell inflammation in a
rabbit model of corneal herpes simplex virus type-1
(HSV-1) infection, after topical treatment with PEDF
plus docosahexaenoic acid (DHA) for 12 weeks, which
was accompanied by improved corneal nerve regener-
ation [19]. The interactions between macrophages and
injured peripheral nerves have been well studied in other
tissues [62, 63], with macrophages responsible for the
phagocytosis of myelin debris. However, most corneal
nerves are unmyelinated or thinly myelinated [2]. Al-
though a previous study has demonstrated a physical as-
sociation between corneal stromal nerve trunks and
resident corneal macrophages in uninjured eyes [29],
further studies are required to investigate how stromal
macrophages may participate in the corneal epithelial
nerve regeneration process.
In order to explore the acute phase inflammatory re-
sponse after exposure of the intact ocular surface to dec-
orin, we measured corneal immune cell density after 6 h
and found a significantly higher density of DCs in the
corneas treated with topical decorin relative to controls.
A recent study has shown a mechanistic association be-
tween corneal intraepithelial DCs and sensory nerves,
with DCs proposed to produce neurotrophic factors,
such as CNTF, which promote corneal nerve regener-
ation after injury [23]. Moreover, Colorado et al. re-
ported that corneal DC density in healthy eyes was
positively correlated with corneal nerve fibre area and
branch density, assessed using in vivo confocal micros-
copy (IVCM) [32]. In addition, a clinical study of pa-
tients with infectious keratitis reported a strong negative
relationship between corneal nerve density and the num-
ber of putative DCs in the central cornea [59].
The contralateral eye effects of immunological and
neural pathology have been well described in human
and animal studies. In humans, the uninfected cornea
contralateral to an infectious keratitis has been shown to
have a heightened DC density, and the cells demonstrate
an altered morphology [64]. In mice, substance P was re-
leased in the eye contralateral to the eye with a neural
injury, involving a sympathetic response [65]. In a mouse
model, Jiao et al. observed enlarged corneal DC
morphology in the eye contralateral to a unilateral cor-
neal epithelial injury [24]. Although no contralateral ef-
fect was observed with topical decorin for corneal SBNP
regeneration and DC density, the macrophages in the
contralateral eye of the decorin-treated eye had a lower
density at 1 week compared to the non-decorin-treated
group. A possible explanation is that decorin may dir-
ectly impact stromal cytokine production, sequestering
growth factors and downregulating chemokines that re-
cruit macrophages. Another explanation is that the im-
proved corneal nerve regeneration locally restores
epithelial homeostasis and thus reduces the epithelial
stress that recruits stromal macrophages. This may also
explain why the change to macrophage density was only
observed at 1 week, when there was a significant im-
provement in nerve regeneration after topical decorin
treatment, supporting our hypothesis that the change to
DCs at early stages of corneal healing may be primarily
responsible for the improved nerve regeneration. These
findings justify future studies to measure the effect of
decorin on cytokine and chemokine expression in the
healthy and injured cornea.
The optically transparent fluid gel used in these stud-
ies is formulated to transition between liquid and solid
states allowing for higher rates of ocular retention whilst
providing a lubricating effect. Decorin fluid gels are
scheduled to enter into Phase IIa clinical trials in 2020
(EudraCT registration: 2017-000389-32) [37]. Although
the fluid gel was introduced to prolong the retention of
decorin on the ocular surface in this study, we did not
observe any difference in the corneal neuroregenerative
effects of decorin fluid gel when compared to decorin
alone. One potential explanation is that topical decorin
was applied three times per day for 1 week or every 2 h
during the early stage (6 h) observation window, which
could be sufficiently frequent to retain an effective con-
centration of decorin on a debrided ocular surface. Ap-
plication in humans though might require the use of
fluid gels to reduce the need for such frequent topical
administration; this would also be expected to have the
added potential effect of lubricating the eye to reduce
irritation.
To further investigate the role of DCs in corneal nerve
regeneration, we applied decorin eye drops following
corneal injury in Cx3cr1gfp/gfp mice that spontaneously
lack resident corneal epithelial DCs. In WT mice, the
decorin-treated eye showed greater regeneration in the
SBNP than the contralateral saline-treated eye in
C57BL/6 J mice. This effect was not observed in
Cx3cr1gfp/gfp mice. These findings suggest that the ab-
sence of DCs might abrogate decorin-mediated corneal
nerve regeneration. Gao et al. have demonstrated that a
local depletion of DCs can delay the corneal nerve re-
generation in a mouse model of corneal epithelial
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debridement, though it was unclear if this delayed nerve
regeneration was isolated to the SBNP or SNTs [23].
Interestingly, another study by the same laboratory re-
ported that intraepithelial DCs produce CNTF that can
promote axon regeneration, providing a potential mech-
anism for DC-dependent corneal nerve regeneration
after injury [66]. A recent study by our group, reported
that eyes treated with a decorin fluid gel had improved
corneal re-epithelialisation 16 days after the induction of
Pseudomonas keratitis [37]. However, it is difficult to
compare epithelial wound healing between studies, as
the infectious model of Pseudomonas keratitis is more
severe than the sterile injury.
In addition, when comparing the sum length of SNTs
between decorin- and saline-treated corneas in WT and
Cx3cr1gfp/gfp, there was no significant difference in either
of the groups. This result may initially appear inconsist-
ent with the results of our first experiment. However,
post hoc review of the initial corneal abrasion areas re-
vealed a significant difference between the two experi-
ments, with the second study having larger wound sizes
(see Supplemental file 6A). Notably, according to our
epithelial wound area data (see Supplemental file 6B)
and other previous studies [67, 68], the area of regener-
ated epithelium was positively correlated with the size of
the initial corneal injury. Therefore, it is possible that
compared to Experiment 1 (WT mice with 1-week
DCN), the relatively larger injured area in Experiment 3
(WT and Cx3cr1gfp/gfp mice with 1-week DCN) may
have initiated a larger re-epithelialised area. We propose
that the regenerated epithelium may have provided more
anatomical structural support for SNTs to sprout in the
acute phase of regeneration. Moreover, it has been
shown that corneal epithelial cells can phagocytose
axonal debris after nerve injury [69]. The removal of
axonal debris plays an important role in the initiation of
the corneal sensory nerve regeneration [70, 71]. There-
fore, the regenerated corneal epithelial cells may provide
a favourable microenvironment for corneal reinnervation
after nerve injury.
Pre-injury, short-duration pre-treatment with dec-
orin did not show any benefits to corneal nerve re-
covery after epithelial injury; however, we did observe
a higher density of DCs in the peripheral epithelium
of the intact cornea. The small sample size (n = 3) of
this proof-of-concept study is acknowledged as a limi-
tation, but the significant finding justified further in-
vestigations to explore how decorin interacts with
DCs in the intact cornea.
Conclusions
Our data provide evidence that topical decorin treat-
ment can promote corneal nerve regeneration, pre-
dominantly in the central SBNP, in part by increasing
the number of DCs in the acute phase post-injury.
The bilateral effects of unilateral decorin instillation
could be triggered by the corneal nerve regeneration,
or as a result of decorin altering the cytokine milieu
of the corneal stroma. It would be interesting to de-
fine the cytokine, chemokine and neuropeptide re-
sponses in corneas (both direct and contralateral)
after treatment with decorin, as well as to determine
the optimal dose of decorin (to inform clinical trans-
lation) and to determine whether the regenerated
nerves provide functional improvements.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12974-020-01812-6.
Additional file 1: Figure S1. Experiment 2: CD45+ dendritic cells (DCs)
after 6-hours of topical treatment (i.e., 3 × doses, 2 hours apart) in CD11c-
eYFP mice. (A) CD45+ CD11c+ DCs in peripheral cornea after decorin
treatment. (B) CD45+ CD11c+ DCs in peripheral cornea after saline treat-
ment. Scale bar (50 μm) applies to all images. Figure S2. Experiment 1:
Initial corneal abrasion area at baseline (Time 0h). Figure S3. Experiment
1: Corneal thickness and epithelial cell proliferation after 1-week of topical
treatment, dosed 3 times/day. (A) Representative SD-OCT images of the
anterior segment from naïve mice. Blue curved line represents the area
of central cornea and blue dashed line represents peripheral cornea.
Scale bar is 200 μm. (B) A higher magnification image of the boxed area
in A. Orange and green double arrows indicate epithelial and stromal
thickness respectively. (C) Corneal epithelial and stromal thickness. There
were no significant inter-group differences. (D) Representative en face
confocal image of Ki67 staining in the central cornea after 1-week treat-
ment of decorin. Scale bar is 50 μm. (E-F) Density of proliferative epithe-
lial cells in the central and peripheral cornea. Summary data are shown
as mean ± SD. Each data point represents one cornea. Red symbols rep-
resent the contralateral eye of the decorin-treated eye. Legend: DCN, dec-
orin; Gel, fluid gel. Figure S4. Experiment 2: Corneal re-epithelialisation
and stromal thickness after 6-hours of topical treatment (i.e., 3 × doses, 2
hours apart). (A) Representative en face OCT image at baseline (0h after
abrasion). (B) Representative en face OCT image after 6-hours of treat-
ment. Red dashed lines in panels A and B indicate the margin of the in-
jured epithelium. Scale bar in B is 0.5 mm. (C) Percentage of re-
epithelialised corneal area after 6-hours of treatment. (D) Corneal stromal
thicknesses after 6-hours of treatment. Red symbols in panels C and D
represent the contralateral eye of the decorin-treated eye. Summary data
are shown as mean ± SD. Each data point represents one cornea. P-
values for each of the inter-group comparisons are provided in Table 2.
Legend: DCN, decorin; Gel, fluid gel. Figure S5. Experiment 4: Effect of
topical decorin applied before injury (DCN) on corneal immune cells and
nerve regeneration. (A-B) Density of DCs in the central and peripheral
corneal epithelium after topical application of prophylactic decorin on in-
tact corneas. (C-D) Sum length of the SNTs and SBNP in the central cor-
nea, at 1 week after prophylactic application of decorin. (E-F) Density of
DCs in the peripheral epithelium and macrophages in the central stroma,
at 1 week after prophylactic application of topical decorin. Summary data
are shown as mean ± SD. * indicates a statistically significant difference
between saline-treated and decorin-treated eyes. Each data point repre-
sents one cornea. Legend: DC, dendritic cell; DCN, decorin; SBNP, sub-
basal nerve plexus; SNT, superficial nerve terminal; WT, wild-type. Figure
S6 (A) Comparison of initial abrasion area between Experiment 1 and 3.
(B) Relationship between the initial abrasion area and the re-
epithelialised area at 6h.
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